BeOne Medicines Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
252.14
+1.84 (0.74%)
At close: Jul 14, 2025, 4:00 PM
252.14
0.00 (0.00%)
After-hours: Jul 14, 2025, 4:20 PM EDT
BeOne Medicines Employees
BeOne Medicines had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$379,624
Profits / Employee
-$35,670
Market Cap
29.87B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11,000 | 400 | 3.77% |
Dec 31, 2023 | 10,600 | 1,600 | 17.78% |
Dec 31, 2022 | 9,000 | 1,000 | 12.50% |
Dec 31, 2021 | 8,000 | 2,700 | 50.94% |
Dec 31, 2020 | 5,300 | 1,800 | 51.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ONC News
- 4 days ago - European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma - Business Wire
- 4 days ago - Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development - Business Wire
- 18 days ago - BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day - Business Wire
- 19 days ago - BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA® - Business Wire
- 4 weeks ago - BeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its Premium - Seeking Alpha
- 4 weeks ago - BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025 - Business Wire
- 4 weeks ago - U.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA® for All Approved Indications - Business Wire
- 4 weeks ago - BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 - Business Wire